Popular Articles

AIG of drugmakers, Pfizer is too big to be guilty
Pfizer Inc sales folks had one tough customer in psychiatrist Stefan Kruszewski. He didn’t buy their pitch to prescribe the anti-psychotic drug Geodon to children, a use that hadn’t been approved by federal regulators. Nor did he go for the so-called off-label uses, such as treating dementia in the elderly, they suggested.

Another accident, one killed
In yet another mishap involving the Delhi Metro, a labourer was killed after he was hit by a steel beam being lifted by a crane at an under-construction metro site in west Delhi early this morning. The incident took place at 5.45 am at Ashok Park Metro station in Punjabi Bagh.

News of the day

Oil India posts 23.5% jump in Q3 net at Rs 717 cr
State-run Oil India Ltd today reported a 23.5 per cent jump in net profit for the third quarter ended December 31, 2009, on the back of higher price-realisation for the crude oil it produces.
Home Business

Private hospital sector may touch Rs 2 lakh cr by 2012: Study

The private hospital sector is expected to touch $45 billion (around Rs 2,00,000 crore) in the next three years riding on growth in Tier-II and Tier-III cities, a study said. - GSK Consumer arm halts operations in AP unit - Piramal to strengthen diagnostic services - Fortis in talks to buy Lanka hospital chain - Piramal Healthcare eyes growing rural market - Apollo to expand pharmacy brand - Piramal Healthcare okays Rs 1K cr fund raising The size of private hospital sector at present is $22 billion, according to a joint study by Assocham and Yes Bank. "Investments by private players in Tier II and Tier III cities are increasingly getting momentum, with rising income levels and exposure to international standards of quality in these cities. Therefore, the sector is expected to rise exponentially," Assocham President Swati Piramal said. The survey said private healthcare sector is poised to be a key contributor to the healthcare industry with substantial private equity investments . Further, it said, the Indian diagnostic and pathology services contribution to healthcare industry may touch $2.5 billion by 2012 against $1.2 billion in 2008-09. Several key players in diagnostic and pathology services have proposed significant investments for expanding in Tier II and Tier III cities, the study said. Dr Lal PathLabs plans to scale up to a size of 50 laboratories with 1,000 collection centres in the next five years with an investment of Rs 35 crore. Piramal Diagnostics plans to invest Rs 100 crore to add 10-15 laboratories by 2012 and increase the number of collection centres to one thousand with an increased focus on Tier II and III towns.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):